Table 1. Effects of IACI in animal stroke models.
Name year | tMCAO | Infusate/supplements | Infusion rate (mL/min) | Infusion duration (min) | Infusion volume (mL) | Time to target temp (min) | Cortical brain temp (°C) | Striatal brain temp (°C) | Body core temp (°C) | Infarct volume (48 h) | Functional outcome (48 h) | Additional end points |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Prereperfusion flushing | ||||||||||||
Ding et al87 | 2 h | Saline 23°C | 2 | 3–4 | 7 | 3–4 | 32–33 | 32–33 | NR | −73% | ↑ | ↓ ICAM-1, ↓leukocyte infiltration,↓vascular plugging |
Saline 37°C | 2 | 3–4 | 7 | — | 37 | 37 | NR | −63% | ↑ | ↓ ICAM-1, ↓leukocyte infiltration,↓ vascular plugging | ||
Ding et al88 | 2 h | Saline 23°C+Heparina | 3 | 3–4 | 8–10 | 3–4 | 32.4 | 33 | 37.5 | −75% | ↑ * | — |
Ding et al89 | 2 h | Saline 37°C | 2 | 3 | 6 | NR | NR | NR | NR | NR | NR | ↓ IL-1β, TNF-α, ↓ICAM-1 |
Ding et al90 | 2 h | Saline 37°C | 2 | 3 | 6 | NR | NR | NR | NR | NR | NR | ↓ Edema↓ MMP-2, ↓MMP-9 |
Prereperfusion IACIs | ||||||||||||
Ding et al97 | 3 h | Saline 20°C | 0.6 | 10 | 6 | ≤10 | 33.4 | 33.9 | >36 | −93% | ↑ * | — |
Li et al95 | 3 h | Saline 20°C | 0.6 | 10 | 6 | NR | NR | NR | NR | −57%* | ↑ * | — |
Luan et al96 | 3 h | Saline 20°C | 0.6 | 10 | 6 | ≤10 | 33.4 | 33.9 | >36 | NR | NR | ↓ ICAM-1, ↓ leukocyte infiltration |
Zhao et al91 | 1.5 h | Saline 20°C | 0.6 | 10 | 6 | ≤10 | 32.8 | 33.2 | 37 | −44%** | ↑** | — |
2 h | Saline 20°C | 0.6 | 10 | 6 | ≤10 | 33.1 | 33.3 | 37.1 | −33%** | ↑** | — | |
2.5 h | Saline 20°C | 0.6 | 10 | 6 | ≤10 | 33.2 | 33.3 | 37.1 | −47%** | ↑** | — | |
3 h | Saline 20°C | 0.6 | 10 | 6 | ≤10 | 32.9 | 33.2 | 37 | ↔** | ↑** | — | |
Song et al93 | 3 h | Saline 15°C | 0.4 | 20 | 8 | 5–10 | 33–34 | 33–34 | 37 | −48% | ↑ | ↔ |
Saline15°C+MgSO4b | 0.4 | 20 | 8 | 5–10 | 33–34 | 33–34 | 37 | −65% | ↑ | ↓ Edema | ||
Chen et al94 | 2 h | Saline 0°C | NR | NR | 2.5 | <3 | 30.5 | 30.8 | NR | −32% | ↑ | — |
Human Albumin 0°Cc | NR | NR | 2.5 | <3 | 30.5 | 30.8 | NR | −67% | ↑ | — | ||
Postreperfusion Intraarterial Cold Infusions | ||||||||||||
Ji et al92 | 3 h | Saline 10°C | 0.25 | 30*** | 7.5 | 20–25 | 34.6 | — | NR | −33% | ↔ | ↓ Edema |
Saline 10°C | 0.25 | 3 × 10*** | 7.5 | 60–70 | 34.6 | — | NR | −32% | ↔ | ↓ Edema, ↓NSE,↓ MMP-9 | ||
Ji et al98 | 2 h | Saline 10°C | 0.17–0.42 | 20*** | NR | NR | 33–34 | — | NR | −54% | ↑ | ↓ Edema, ↓NSE,↓S100β |
+1 h Rep. | Saline 10°C | 0.17–0.42 | 20*** | NR | NR | 33–34 | — | NR | −42% | ↑ | ↓ Edema, ↓S100β | |
+2 h Rep. | Saline 10°C | 0.17–0.42 | 20*** | NR | NR | 33–34 | — | NR | −31% | ↑ | ↓ S100β |
IACI, intraarterial cold infusion; ICAM, intracellular adhesion molecule; IL1β, interleukin-1β; MMP-9, matrix metalloproteinase-9; NR, not reported; NSE, neuron-specific enolase; TNF-α, tumor necrosis factor-α; tMCAO, transient middle cerebral artery occlusion.
Effects of intraarterial infusions into the ICA in animal models of stroke in comparison to untreated animals: All experiments were conducted in rats. Prereperfusion flushing uses high infusion rates and relatively high infusion temperatures (23°C to 37°C) to remove vasoactive and inflammatory substances before blood supply to the ischemic tissue is reestablished. Intraarterial cold infusions use lower infusion rates and low infusion temperatures (≤20°C) to induce selective brain hypothermia. Infusions are either started before or after blood flow to the ischemic tissue is reestablished (prereperfusion and postreperfusion infusions).
40 IE/mL.
120 mg/kg body weight.
500 mg/kg body weight, *28 days, ** compared with permanent ischemia, ***active rewarming after infusion.